Observational analysis identifies plasma proteins as mediators of secondary disease in UK Biobank participants, suggesting novel therapeutic targets.
Key Points
Plasma proteins act as mediators, linking primary diseases like diabetes and hypertension to secondary conditions.
The study found 1,461 significant mediation pathways involving 395 plasma proteins, indicating complex interactions in disease development.
Using data from ~50,000 participants, Mendelian randomization confirmed causal roles for 84 proteins, emphasizing their therapeutic potential.
Results showed improved predictive accuracy for secondary disease risks, particularly with proteins like APOE and GDF15, highlighting their importance.